News

The company has submitted a new drug application to the Ministry of Health, Labour and Welfare in Japan for prasugrel. Data from phase 3 trial carried out in

The $1m funding will support later stage clinical trial of inhaled formulation of levodopa that is developed as an adjunct PRN therapy offering relief from intermittent debilitating motor

The acquirer, which already holds 50% stake in the company, said that the change of ownership will be completed on 1 July 2013. Founded in 2002 to manufacture

DigestaCare Naturel is formulated with 300mg of proprietary enzyme blend, including protease enzymes effective in a wide pH range in the digestive tract. Providing natural enzymes that aid

The offer includes the transfer of GSK’s Arixtra and Fraxiparine brands, not including China, India and Pakistan, in addition to associated manufacturing site to Aspen. Employees at NDB

Padilha was quoted by Xinhua news agency as saying that the country has the technology which can help patients with easy and quick access to the drug when

The investment increases the plant’s capacity of manufacturing advanced chemical bond products for hygiene applications to fulfill the increasing needs of customers in the region. The new facility

Besides offering filling services for Schedule 2, 2N, 3, 3N, 4, and 5 controlled substances, this expanded registration will allow Burlington to offer these services to complement more

Fiocruz is an arm of the Brazilian Ministry of Health and alfataliglicerase is the company’s enzyme replacement therapy for the rare lysosomal storage disorder. Protalix president and CEO